RecruitingNot ApplicableNCT05475574

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit

Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae (ESBLE) in a Geriatric Unit: an Interventional Prospective Noninferiority Non-randomized Double-blind Controlled Before and After Study

Sponsor

Centre Hospitalier Régional Metz-Thionville

Enrollment

954 participants

Start Date

Mar 7, 2023

Study Type

INTERVENTIONAL

Conditions

Infection, Hospital

Summary

This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.

Eligibility

Min Age: 65 Years

Inclusion Criteria7

Adult patient (> 65 years old)
Patient hospitalized in geriatrics during the study period
Free and informed consent obtained from the patient (or his trusted person or legal representative) within 48 hours of its admission at the geriatric unit
Patient affiliated to a social security scheme
Patient requiring contact precaution for an indication other than ESBLE (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC) on admission
Patient under legal protection
Person deprived of liberty

Exclusion Criteria2

Patient requiring contact precaution for an indication other than ESBL during the patient stay (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC)
Patient's stay period less than 4 days

Interested in this trial?

Get notified about updates and connect with the research team.